The PE ratio for Laboratory Corp Of America Holdings stock stands at 47.05 as of Feb 21, 2025. This takes into account the latest EPS of $5.31 and stock price of $249.85. An increase of 11% has been observed in the PE ratio compared to its average of 42.5 of the last four quarters.
Over the last ten years, the average PE ratio of Laboratory Corp Of America Holdings has been 21.76. The current 47.05 P/E ratio is 116% higher than the historical average. Looking back at the last ten years, LH's PE ratio peaked in the Dec 2023 quarter at 47.35, with a price of $227.29 and an EPS of $4.8. The Jun 2021 quarter marked the lowest point at 9.34, with a price of $275.85 and an EPS of $29.54.
Maximum annual increase: 182.52% in 2023
Maximum annual decrease: -36.64% in 2020
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 47.35 | 182.52% | $227.29 | $4.8 |
2022 | 16.76 | 31.25% | $235.48 | $14.05 |
2021 | 12.77 | 0.31% | $314.21 | $24.6 |
2020 | 12.73 | -36.64% | $203.55 | $15.99 |
2019 | 20.09 | 38.46% | $169.17 | $8.42 |
2018 | 14.51 | 9.1% | $126.36 | $8.71 |
2017 | 13.3 | -28.11% | $159.51 | $11.99 |
2016 | 18.5 | -33.72% | $128.38 | $6.94 |
2015 | 27.91 | 56.01% | $123.64 | $4.43 |
2014 | 17.89 | 24.5% | $107.9 | $6.03 |
2013 | 14.37 | 1.05% | $91.37 | $6.36 |
2012 | 14.22 | -13.97% | $86.62 | $6.09 |
2011 | 16.53 | 1.91% | $85.97 | $5.2 |
2010 | 16.22 | 9.67% | $87.92 | $5.42 |
2009 | 14.79 | -2.89% | $74.84 | $5.06 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 42.09 | 11.88% | $223.48 | $5.31 |
Jun 2024 | 37.62 | -12.18% | $203.51 | $5.41 |
Mar 2024 | 42.84 | -9.52% | $218.46 | $5.1 |
Dec 2023 | 47.35 | 79.49% | $227.29 | $4.8 |
Sep 2023 | 26.38 | 2.85% | $201.05 | $7.62 |
Jun 2023 | 25.65 | 24.88% | $241.33 | $9.41 |
Mar 2023 | 20.54 | 22.55% | $229.42 | $11.17 |
Dec 2022 | 16.76 | 54.47% | $235.48 | $14.05 |
Sep 2022 | 10.85 | -2.43% | $204.81 | $18.88 |
Jun 2022 | 11.12 | -7.33% | $234.36 | $21.07 |
Mar 2022 | 12 | -6.03% | $263.66 | $21.98 |
Dec 2021 | 12.77 | 28.99% | $314.21 | $24.6 |
Sep 2021 | 9.9 | 6% | $281.44 | $28.42 |
Jun 2021 | 9.34 | -0.64% | $275.85 | $29.54 |
Mar 2021 | 9.4 | -26.16% | $255.03 | $27.12 |
Currently, LH's PE ratio is higher than the 3, 5 and 10-year averages.
In comparison to its peer QGEN, LH's PE ratio is lower, but it is higher than IDXX's and DGX's.
Stock name | PE ratio | Market cap |
---|---|---|
DGX Quest Diagnostics Inc | 22.14 | $19.11B |
IDXX Idexx Laboratories Inc | 42.04 | $36.82B |
LH Laboratory Corp Of America Holdings | 47.05 | $20.9B |
QGEN Qiagen NV | 106.95 | $8.86B |
NEO Neogenomics Inc | N/A | $1.43B |
ENZ Enzo Biochem Inc | N/A | $26.98M |
As of Feb 21, 2025, LH stock has a price to earnings ratio of 47.05.
The 3-year average price to earnings ratio for LH stock is 26.65.
The 5-year average price to earnings ratio for LH stock is 23.81.
Over the last ten years, the quarterly PE ratio reached its highest level at 47.35 in the Dec 2023 quarter.
LH's price to earnings ratio is currently 116% above its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Feb 21, 2025), Laboratory Corp Of America Holdings's share price is $249.85. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $5.31. Therefore, Laboratory Corp Of America Holdings's PE ratio for today is 47.05. PE RATIO(47.05) = STOCK PRICE($249.85) / TTM EPS($5.31)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.